| pubmed-article:9658366 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9658366 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:9658366 | lifeskim:mentions | umls-concept:C0332307 | lld:lifeskim |
| pubmed-article:9658366 | lifeskim:mentions | umls-concept:C0021747 | lld:lifeskim |
| pubmed-article:9658366 | lifeskim:mentions | umls-concept:C0439185 | lld:lifeskim |
| pubmed-article:9658366 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:9658366 | pubmed:dateCreated | 1998-9-17 | lld:pubmed |
| pubmed-article:9658366 | pubmed:abstractText | The Type I interferons are a family of closely related cytokines that have antiviral and immunostimulatory properties. There has been prolonged debate regarding the different interferon-alpha subtypes: with some authorities suggest that the different interferons have essentially similar properties but others argue that there are significant differences between them. Recent work has shown that the various interferon-alpha subtypes can interact with the interferon receptor components in different ways and can activate a number of different signalling pathways. Recent studies on the immunomodulatory properties of the Type I interferons indicate that there are profound differences between the subtypes. The clinical significance of all these differences remains to be determined. | lld:pubmed |
| pubmed-article:9658366 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9658366 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9658366 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9658366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9658366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9658366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9658366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9658366 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9658366 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9658366 | pubmed:month | May | lld:pubmed |
| pubmed-article:9658366 | pubmed:issn | 1352-0504 | lld:pubmed |
| pubmed-article:9658366 | pubmed:author | pubmed-author:FinterN BNB | lld:pubmed |
| pubmed-article:9658366 | pubmed:author | pubmed-author:FosterG RGR | lld:pubmed |
| pubmed-article:9658366 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9658366 | pubmed:volume | 5 | lld:pubmed |
| pubmed-article:9658366 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9658366 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9658366 | pubmed:pagination | 143-52 | lld:pubmed |
| pubmed-article:9658366 | pubmed:dateRevised | 2005-11-16 | lld:pubmed |
| pubmed-article:9658366 | pubmed:meshHeading | pubmed-meshheading:9658366-... | lld:pubmed |
| pubmed-article:9658366 | pubmed:meshHeading | pubmed-meshheading:9658366-... | lld:pubmed |
| pubmed-article:9658366 | pubmed:meshHeading | pubmed-meshheading:9658366-... | lld:pubmed |
| pubmed-article:9658366 | pubmed:meshHeading | pubmed-meshheading:9658366-... | lld:pubmed |
| pubmed-article:9658366 | pubmed:meshHeading | pubmed-meshheading:9658366-... | lld:pubmed |
| pubmed-article:9658366 | pubmed:meshHeading | pubmed-meshheading:9658366-... | lld:pubmed |
| pubmed-article:9658366 | pubmed:meshHeading | pubmed-meshheading:9658366-... | lld:pubmed |
| pubmed-article:9658366 | pubmed:meshHeading | pubmed-meshheading:9658366-... | lld:pubmed |
| pubmed-article:9658366 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9658366 | pubmed:articleTitle | Are all type I human interferons equivalent? | lld:pubmed |
| pubmed-article:9658366 | pubmed:affiliation | Imperial College School of Medicine, St Mary's Hospital, London, UK. | lld:pubmed |
| pubmed-article:9658366 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9658366 | pubmed:publicationType | Review | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9658366 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9658366 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9658366 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9658366 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9658366 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9658366 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9658366 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9658366 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9658366 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9658366 | lld:pubmed |
